Roche gains FDA breakthrough status for Tecentriq combination
Roche has obtained breakthrough therapy designation from the US Food and Drug Administration (FDA) for the combination of Tecentriq (atezolizumab)…
hepatocellular carcinoma
Roche has obtained breakthrough therapy designation from the US Food and Drug Administration (FDA) for the combination of Tecentriq (atezolizumab)…